UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weight Loss Versus Glycemic Control as the Primary Treatment Target in Newly Diagnosed Type 2 Diabetes: Why Choose When You Can Have Both?

Drugs (New York, N.Y.), 2023-04, Vol.83 (6), p.469-477

2023

Volltextzugriff (PDF)

Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis

Nutrients, 2020-08, Vol.12 (8), p.2436

2020

Volltextzugriff (PDF)

A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery Disease

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022-07, Vol.22 (4), p.357-361

2022

Volltextzugriff (PDF)

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic

Quality of life research, 2022-01, Vol.31 (1), p.193-204

2022

Volltextzugriff (PDF)

Lipid testing in infectious diseases: possible role in diagnosis and prognosis

Infection, 2017-10, Vol.45 (5), p.575-588

2017

Volltextzugriff (PDF)

Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors

Atherosclerosis, 2020-09, Vol.309, p.67-69

2020

Volltextzugriff (PDF)

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

International journal of cardiology, 2021-12, Vol.345, p.119-124

2021

Volltextzugriff (PDF)

Multiple actions of high-density lipoprotein

Current opinion in cardiology, 2008-07, Vol.23 (4), p.370-378

2008

Volltextzugriff (PDF)

Canagliflozin and Amputation Risk: Evidence So Far

International journal of lower extremity wounds, 2020-03, Vol.19 (1), p.21-26

2020

Volltextzugriff (PDF)

Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention

Nutrients, 2023-06, Vol.15 (13), p.2845

2023

Volltextzugriff (PDF)

Non-Classical Aspects of Obesity Pathogenesis and Their Relative Clinical Importance for Obesity Treatment

Healthcare (Basel), 2023-05, Vol.11 (9), p.1310

2023

Volltextzugriff (PDF)

Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications

Pharmaceuticals (Basel, Switzerland), 2023-05, Vol.16 (5), p.750

2023

Volltextzugriff (PDF)

Vitamin D and metabolic syndrome: is there a link?

Current pharmaceutical design, 2010-10, Vol.16 (30), p.3417-3434

2010

Volltextzugriff (PDF)

Novel roles of vitamin D in disease: What is new in 2011?

European journal of internal medicine, 2011-08, Vol.22 (4), p.355-362

2011

Volltextzugriff (PDF)

Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia

European journal of preventive cardiology, 2020-01, Vol.27 (2), p.157-165

2020

Volltextzugriff (PDF)

Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH

Current pharmaceutical design, 2021-01, Vol.27 (21), p.2537-2544

2021

Volltextzugriff (PDF)

Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications

Current medicinal chemistry, 2018-01, Vol.25 (13), p.1549-1566

2018

Volltextzugriff (PDF)

Lipoprotein(a) reduction with proprotein convertase subtilisin/kexin type 9 inhibitors: An unsolved mystery

European journal of preventive cardiology, 2021-08, Vol.28 (8), p.813-815

Liberopoulos, Evangelos

2021

Volltextzugriff (PDF)

Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries

Current pharmaceutical design, 2018-01, Vol.24 (31), p.3605-3615

2018

Volltextzugriff (PDF)

Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation

International journal of cardiology, 2017-11, Vol.247, p.18-18

2017

Volltextzugriff (PDF)

Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity

Journal of cardiology, 2019-09, Vol.74 (3), p.290-295

2019

Volltextzugriff (PDF)

Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review

Journal of cardiovascular development and disease, 2021-02, Vol.8 (2), p.18

2021

Volltextzugriff (PDF)

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy

Case reports in endocrinology, 2019-01, Vol.2019 (2019), p.1-4

2019

Volltextzugriff (PDF)

The Impact of Dietary Carbohydrates on Inflammation-Related Cardiovascular Disease Risk: The ATTICA Study (2002–2022)

Nutrients, 2024-07, Vol.16 (13), p.2051

2024

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(199)

Publikationsform

Artikel
(252)
Berichte
(3)

Sprache

Englisch
(255)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(176)
Science & Technology
(176)
Humans
(119)
Cardiovascular System & Cardiology
(72)
Male
(64)
Female
(63)
Middle Aged
(57)
Cardiac & Cardiovascular Systems
(52)
Risk Factors
(47)
Aged
(42)
Pharmacology & Pharmacy
(40)
Cardiovascular Disease
(37)
Adult
(32)
Peripheral Vascular Disease
(28)
Diabetes
(27)
Treatment Outcome
(27)
Cholesterol
(26)
General & Internal Medicine
(23)
Medicine, General & Internal
(22)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Weight Loss Versus Glycemic Control as the Primary Treatment Target in Newly Diagnosed Type 2 Diabetes: Why Choose When You Can Have Both?

Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis

A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery Disease

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic

Lipid testing in infectious diseases: possible role in diagnosis and prognosis

Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

Multiple actions of high-density lipoprotein

Canagliflozin and Amputation Risk: Evidence So Far

Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention

Non-Classical Aspects of Obesity Pathogenesis and Their Relative Clinical Importance for Obesity Treatment

Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications

Vitamin D and metabolic syndrome: is there a link?

Novel roles of vitamin D in disease: What is new in 2011?

Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia

Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH

Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications

Lipoprotein(a) reduction with proprotein convertase subtilisin/kexin type 9 inhibitors: An unsolved mystery

Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries

Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)

Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation

Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity

Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy

The Impact of Dietary Carbohydrates on Inflammation-Related Cardiovascular Disease Risk: The ATTICA Study (2002–2022)

Suchergebnisse filtern